Ngā hua rapu kaituhi :: APM

1

$Pembrolizumab in relapsed or refractory Richter syndrome$

Pembrolizumab in relapsed or refractory Richter syndrome mā Philippe Armand, Niels Murawski, Daniel Molin, Jasmine Zain, Barbara Eichhorst, Zafer Gülbaş, Eliza A. Hawkes, John M. Pagel, Tycel Phillips, Vincent Ribrag, Jakub Svoboda, Anastasios Stathis, Arkendu Chatterjee, Robert Orlowski, Patricia Marinello, Beth Christian

I whakaputaina 2020

Whiwhi kuputuhi katoa
Carta

Tiaki ki tētahi rārangi

I tiakina i:
2

$Efficacy and safety of pembrolizumab in relapsed/refractory primary mediastinal large B‐cell lymphoma (rrPMBCL): interim analysis of the KEYNOTE‐170 phase 2 trial$

Efficacy and safety of pembrolizumab in relapsed/refractory primary mediastinal large B‐cell lymphoma (rrPMBCL): interim analysis of the KEYNOTE‐170 phase 2 trial mā Pier Luigi Zinzani, Catherine Thiéblemont, В Я Мельниченко, Dzhelil Osmanov, Krimo Bouabdallah, Jan Walewski, Alejandro Majlis, Laura Fogliatto, M. D. Caballero Barrigón, Christian Bach, Zafer Gülbaş, Muhi̇t Özcan, Gilles Salles, Margaret A. Shipp, Arun Balakumaran, Sabine Chlosta, Arkendu Chatterjee, Philippe Armand

I whakaputaina 2017

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
3

Pegbelfermin in Patients With Nonalcoholic Steatohepatitis and Stage 3 Fibrosis (FALCON 1): A Randomized Phase 2b Study mā Rohit Loomba, Arun J. Sanyal, Atsushi Nakajima, Brent A. Neuschwander‐Tetri, Zachary Goodman, Stephen A. Harrison, Eric Lawitz, Nadege Gunn, Kento Imajo, Natarajan Ravendhran, Takemi Akahane, Bradly Boone, Masayuki Yamaguchi, Arkendu Chatterjee, Giridhar Tirucherai, Diane E. Shevell, Shuyan Du, Edgar D. Charles, Manal F. Abdelmalek

I whakaputaina 2023

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
4

Pegbelfermin in Patients With Nonalcoholic Steatohepatitis and Compensated Cirrhosis (FALCON 2): A Randomized Phase 2b Study mā Manal F. Abdelmalek, Arun J. Sanyal, Atsushi Nakajima, Brent A. Neuschwander‐Tetri, Zachary Goodman, Eric Lawitz, Stephen A. Harrison, Ira M. Jacobson, Kento Imajo, Nadege Gunn, Dina Halegoua‐DeMarzio, Takemi Akahane, Bradly Boone, Masayuki Yamaguchi, Arkendu Chatterjee, Giridhar Tirucherai, Diane E. Shevell, Shuyan Du, Edgar D. Charles, Rohit Loomba

I whakaputaina 2023

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
5

Pembrolizumab for previously treated advanced anal squamous cell carcinoma: results from the non-randomised, multicohort, multicentre, phase 2 KEYNOTE-158 study mā Aurélien Marabelle, Philippe A. Cassier, Marwan Fakih, Steven Kao, Dorte Nielsen, Antoîne Italiano, Tormod Kyrre Guren, Marloes G. J. van Dongen, Kristen Spencer, Giovanni M. Bariani, Paolo A. Ascierto, Armando Santoro, Manisha H. Shah, Jamil Asselah, Syma Iqbal, Shunji Takahashi, Sarina A. Piha‐Paul, Patrick A. Ott, Arkendu Chatterjee, Fan Jin, Kevin Norwood, Jean‐Pierre Delord

I whakaputaina 2022

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
6

A Phase Ib Dose-Escalation Study of Encorafenib and Cetuximab with or without Alpelisib in Metastatic<i>BRAF</i>-Mutant Colorectal Cancer mā Robin M.J.M. van Geel, Josep Tabernero, Elena Élez, Johanna C. Bendell, Anna Spreafico, Martin Schüler, Takayuki Yoshino, Jean‐Pierre Delord, Yasuhide Yamada, Martijn P. Lolkema, Jason E. Faris, Ferry A.L.M. Eskens, Sunil Sharma, Rona Yaeger, Heinz‐Josef Lenz, Zev A. Wainberg, Emin Avşar, Arkendu Chatterjee, Savina Jaeger, Eugene Tan, Kati Maharry, Tim Demuth, Jan H.M. Schellens

I whakaputaina 2017

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
7

$Pembrolizumab in Patients with Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma (PMBCL): Data from the Keynote-013 and Keynote-170 Studies$

Pembrolizumab in Patients with Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma (PMBCL): Data from the Keynote-013 and Keynote-170 Studies mā Philippe Armand, Scott J. Rodig, В Я Мельниченко, Catherine Thiéblemont, Krimo Bouabdallah, Gayane Tumyan, Muhi̇t Özcan, Sergio Portiño, Laura Fogliatto, Dolores Caballero, Jan Walewski, Zafer Gülbaş, Vincent Ribrag, Beth Christian, Guilherme Fleury Perini, Gilles Salles, Jakub Svoboda, Jasmine Zain, Sanjay S. Patel, Pei-Hsuan Chen, Azra H. Ligon, Jing Ouyang, Donna Neuberg, Robert Redd, Arkendu Chatterjee, Robert Orlowski, Arun Balakumaran, Margaret A. Shipp, Pier Luigi Zinzani

I whakaputaina 2018

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
8

$Pembrolizumab in Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma$

Pembrolizumab in Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma mā Philippe Armand, Scott J. Rodig, В Я Мельниченко, Catherine Thiéblemont, Kamal Bouabdallah, Gayane Tumyan, Muhıt Özcan, Sergio Portiño, Laura Fogliatto, Marı́a Dolores Caballero, Jan Walewski, Zafer Gülbaş, Vincent Ribrag, Beth Christian, Guilherme Fleury Perini, Gilles Salles, Jakub Svoboda, Jasmine Zain, Sanjay S. Patel, Pei-Hsuan Chen, Azra H. Ligon, Jing Ouyang, Donna Neuberg, Robert Redd, Arkendu Chatterjee, Arun Balakumaran, Robert Orlowski, Margaret A. Shipp, Pier Luigi Zinzani

I whakaputaina 2019

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i: